Published in Cancer Weekly, December 15th, 2009
Researchers performed an analysis of over 100,000 patients with stage IV non-small cell lung cancer (NSCLC) identified through the SEER database to evaluate trends in survival between 1990 and 2005 to assess the true impact of recent medical advances on these patients. Daniel Morgensztern, MD of the Washington University School of Medicine and his team reviewed over 16 years of records from those in the unselected...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2009-12-15)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.